MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/00054725-199808000-00009

Медицинская библиотека · Inflammatory bowel diseases · 1998

Which immunosuppressors do you use to treat Crohn's disease and ulcerative colitis? In which order of priority and how worried are you about toxicity?

Schölmerich J

СтатьяОбзорПеревод пока не подготовлен

Аннотация

In severe and steroid-refractory UC, intravenous cyclosporin A is an effective tool to induce rapid remission. Short-term side effects can be dealt with, and decisions on further treatment can be made without emergency. AZA/6-MP can be used in steroid-dependent or chronically active disease and probably to maintain cyclosporin A-induced remission if surgery is not possible or not accepted. The latter should be discussed with the patient and an experienced surgeon. Other immunosuppressors do not play a role in my approach to this disease. In CD, AZA/6-MP is useful for steroid-refractory and -dependent patients. Again toxicity is limited and can be handled. This treatment should be used more frequently and is my approach of choice if fibrous stenoses, as cause of chronic activity, are excluded. MTX can be used as second-line treatment. I am worried about its long-term toxicity, in particular to the liver, as described in rheumatic disorders. Both intravenous cyclosporin A and AZA/6-MP should be used by those having experience with these drugs (and IBD). They are much needed and helpful.

Для цитирования: Schölmerich J. Which immunosuppressors do you use to treat Crohn's disease and ulcerative colitis? In which order of priority and how worried are you about toxicity?. Inflammatory bowel diseases. 1998. DOI: 10.1097/00054725-199808000-00009.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.